Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Context Therapeutics Inc.

Clinical trials sponsored by Context Therapeutics Inc., explained in plain language.

Context Therapeutics Inc. CNTX NASDAQ

A clinical-stage biopharmaceutical company developing cancer therapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet recruiting 1 Terminated 1

New antibody drug takes aim at Hard-to-Treat cancers

Disease control Not yet recruiting

This early-stage trial tests a new drug called CT-202 in people with advanced triple-negative breast cancer, colorectal cancer, or bladder cancer that has come back or spread. The drug is a bispecific antibody designed to help the immune system attack cancer cells that have a pro…

Phase: PHASE1 • Sponsor: Context Therapeutics Inc. • Aim: Disease control

Last updated Jul 11, 2026 00:00 UTC